… chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A global, multicenter, randomized, double-blind, phase 3 trial (AK105-304)
用户5TLJU3iD5n3A
3个月前
135
10
已关闭
DOI:
文献链接:
其他信息:
C Hu, X Chen, T Xu, S Huang, F Liu, S Qu…
Cancer …, 2025
aacrjournals.org
… This presentation reports the results of a global phase 3 clinical trial with ethnically … treated with penpulimab plus chemotherapy vs. placebo plus chemotherapy as the first-line therapy …